Compare Stocks: PFNX, BIO, and TRIL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIO Bio-Rad Laboratories	$355.56 -1.6%	$308.58	$236.73 ▼ $365.00	$9.66B	1.06	314,697 shs	173,818 shs
PFNX Pfenex	$12.75	$12.75	$5.26 ▼ $14.00	$437.29M	N/A	503,865 shs	N/A
TRIL Defiance Trillion Dollar Club Index ETF	$19.86	$18.12	$5.80 ▼ $20.96	$2.09B	2.08	1.87 million shs	N/A

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIO Bio-Rad Laboratories	-1.40%	+0.81%	+20.06%	+43.57%	+23.79%
PFNX Pfenex	0.00%	0.00%	0.00%	0.00%	0.00%
TRIL Defiance Trillion Dollar Club Index ETF	0.00%	0.00%	0.00%	0.00%	+7.72%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIO Bio-Rad Laboratories	$355.56 -1.6%	$308.58	$236.73 ▼ $365.00	$9.66B	1.06	314,697 shs	173,818 shs
PFNX Pfenex	$12.75	$12.75	$5.26 ▼ $14.00	$437.29M	N/A	503,865 shs	N/A
TRIL Defiance Trillion Dollar Club Index ETF	$19.86	$18.12	$5.80 ▼ $20.96	$2.09B	2.08	1.87 million shs	N/A

The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIO Bio-Rad Laboratories	-1.40%	+0.81%	+20.06%	+43.57%	+23.79%
PFNX Pfenex	0.00%	0.00%	0.00%	0.00%	0.00%
TRIL Defiance Trillion Dollar Club Index ETF	0.00%	0.00%	0.00%	0.00%	+7.72%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIO Bio-Rad Laboratories	2.00	Hold	$343.33	-3.44% Downside
PFNX Pfenex	0.00	N/A	N/A	N/A
TRIL Defiance Trillion Dollar Club Index ETF	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest PFNX, BIO, and TRIL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/11/2026	BIO Bio-Rad Laboratories	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/5/2026	BIO Bio-Rad Laboratories	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral ➝ Hold	$300.00 ➝ $330.00
8/5/2026	BIO Bio-Rad Laboratories	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$320.00 ➝ $370.00
8/5/2026	BIO Bio-Rad Laboratories	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Equal Weight	$310.00 ➝ $330.00
8/3/2026	BIO Bio-Rad Laboratories	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
7/13/2026	BIO Bio-Rad Laboratories	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
5/15/2026	BIO Bio-Rad Laboratories	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$320.00

(Data available from 8/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIO Bio-Rad Laboratories	$2.58B	3.68	$9.87 per share	36.04	$268.30 per share	1.33
PFNX Pfenex	N/A	N/A	N/A	N/A	N/A	N/A
TRIL Defiance Trillion Dollar Club Index ETF	$150K	13,903.44	N/A	N/A	$2.56 per share	7.76

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIO Bio-Rad Laboratories	$759.90M	$8.25	43.10	39.38	N/A	8.59%	3.54%	2.48%	10/29/2026 (Estimated)
PFNX Pfenex	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TRIL Defiance Trillion Dollar Club Index ETF	-$59.35M	$0.62	32.04	N/A	N/A	N/A	-23.31%	-18.66%	N/A

Latest PFNX, BIO, and TRIL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/4/2026	Q2 2026	BIO Bio-Rad Laboratories	$1.75	$2.62	+$0.87	$13.85	$623.99 million	$651.00 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIO Bio-Rad Laboratories	N/A	N/A	N/A	N/A	N/A
PFNX Pfenex	N/A	N/A	N/A	N/A	N/A
TRIL Defiance Trillion Dollar Club Index ETF	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIO Bio-Rad Laboratories	0.11	3.14	2.33
PFNX Pfenex	N/A	N/A	N/A
TRIL Defiance Trillion Dollar Club Index ETF	N/A	19.82	19.82

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIO Bio-Rad Laboratories	65.24%
PFNX Pfenex	N/A
TRIL Defiance Trillion Dollar Club Index ETF	87.15%

Insider Ownership

Company	Insider Ownership
BIO Bio-Rad Laboratories	30.34%
PFNX Pfenex	N/A
TRIL Defiance Trillion Dollar Club Index ETF	9.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIO Bio-Rad Laboratories	7,450	26.74 million	18.64 million	Optionable
PFNX Pfenex	71	34.30 million	N/A	Not Optionable
TRIL Defiance Trillion Dollar Club Index ETF	33	105.00 million	95.44 million	No Data

PFNX, BIO, and TRIL Headlines

Recent News About These Companies

The Trillion-Dollar Club: Mega-Cap Stocks With Market Caps Over $1 Trillion

June 17, 2026 | money.usnews.com

ETF Prime: Murphy on the New Faces of the ETF Boom

October 29, 2025 | etftrends.comE

Defiance Trillion Dollar Club Index ETF

October 21, 2025 | money.usnews.com

Tidal Trust II - Defiance Trillion Dollar Club Index ETF

October 16, 2025 | money.usnews.com

Trillion-Dollar Inflows: ETFs Become the Market’s New “Pulse”

October 16, 2025 | nai500.comN

The Future Of Psychedelic-Inspired Therapeutics: No-Trip Neuroplastogens

August 14, 2025 | lifescienceleader.comL

Pfizer Ends Mid-Stage Trial for CD47 Blood Cancer Drug, Citing Recruitment Problems

July 1, 2025 | biospace.comB

Ratio Therapeutics and TerraPower Isotopes Sign Supply Agreement for Actinium-225 For Targeted Radiotherapeutics

June 20, 2025 | finance.yahoo.com

Trillium Therapeutics Stock Price History

May 26, 2025 | investing.com

TTI Consumer Power Tools, Inc. is Seeking an IP Paralegal

September 26, 2024 | ipwatchdog.comI

Advances in Drug Discovery & Development 2024

September 8, 2024 | technologynetworks.comT

When You Look Back in 5 Years, You'll Wish You'd Bought This $2 Trillion Artificial Intelligence (AI) Stock

July 30, 2024 | finance.yahoo.com

Google Cloud unveils the Trillium TPU, its most powerful AI processor so far

May 14, 2024 | siliconangle.comS

Cachet Bicycle shakes off COVID

February 25, 2024 | baytoday.caB

Rejuvenate your look with a trip to Fourth Avenue Medical Aesthetics

January 30, 2024 | chch.comC

TTI apprehends motorists for illegal removal of clamps, hunt for four others underway

January 30, 2024 | bulawayo24.comB

BridgeBio raises $1.25bn, and other biotech financings

January 19, 2024 | pharmaphorum.comP

Ratio Therapeutics Raises $50M in Series B Financing

January 17, 2024 | precisionmedicineonline.comP

Leiomyosarcoma Drug Pipeline Report 2023 - ResearchAndMarkets.com

November 10, 2023 | businesswire.com

Mirati Therapeutics Stock (NASDAQ:MRTX), Analyst Ratings, Price Targets, Predictions

November 8, 2023 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

PFNX, BIO, and TRIL Company Descriptions

Bio-Rad Laboratories NYSE:BIO

$355.56 -5.63 (-1.56%)

Closing price 08/14/2026 03:59 PM Eastern

Extended Trading

$356.36 +0.80 (+0.22%)

As of 08/14/2026 07:34 PM Eastern

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Pfenex NYSEAMERICAN:PFNX

$12.75 0.00 (0.00%)

As of 10/1/2020

Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidates include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis; and novel anthrax vaccine candidates, such as Px563L and RPA563 that have completed Phase Ia clinical study. The company also develops PF582, a biosimilar candidate to Lucentis; PF529, a biosimilar to Neulasta; and hematology/oncology products, including PF743, a recombinant crisantaspase, as well as PF745, a recombinant crisantaspase with half-life extension technology. In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California.

Defiance Trillion Dollar Club Index ETF NASDAQ:TRIL

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFNX, BIO, and TRIL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFNX, BIO, and TRIL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFNX, BIO, and TRIL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PFNX, BIO, and TRIL Company Descriptions

Bio-Rad Laboratories NYSE:BIO

Pfenex NYSEAMERICAN:PFNX

Defiance Trillion Dollar Club Index ETF NASDAQ:TRIL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFNX, BIO, and TRIL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFNX, BIO, and TRIL Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFNX, BIO, and TRIL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

PFNX, BIO, and TRIL Company Descriptions

Bio-Rad Laboratories NYSE:BIO

Pfenex NYSEAMERICAN:PFNX

Defiance Trillion Dollar Club Index ETF NASDAQ:TRIL

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools